Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Tables)

v3.20.1
Stockholders' Equity (Tables)
12 Months Ended
Mar. 31, 2020
Summary of stock-based compensation expense by statement of operations line item

The following table summarizes, by statement of operations line item, stock-based compensation expense for the fiscal years ended March 31, 2020 and 2019 (in thousands):

 

 

 

 

 

 

 

 

 

 

Year Ended

 

 

 

March 31,

 

 

 

2020

    

2019

 

Cost of goods sold

 

$

69

    

$

51

 

Research and development

 

 

44

 

 

32

 

Selling, general and administrative

 

 

800

 

 

824

 

Stock-based compensation expense

 

$

913

 

$

907

 

 

Summary of stock option activity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

 

Weighted-

 

Remaining

 

Aggregate

 

 

 

 

 

Average

 

Contractual

 

Intrinsic

 

 

 

Shares

 

Exercise Price

 

Term

 

Value

 

 

 

 

 

 

 

 

(in years)

 

 

 

 

Options outstanding at March 31, 2019

    

17,499

    

$

209.36

    

 

    

 

 

 

Granted

 

 —

 

$

 —

 

 

 

 

 

 

Exercised

 

 —

 

$

 —

 

 

 

 

 

 

Forfeited, cancelled or expired

 

(6,250)

 

$

198.21

 

 

 

 

 

 

Options outstanding at March 31, 2020

 

11,249

 

$

215.56

 

2.1

 

 

 —

 

Options fully vested at March 31, 2020 and those expected to vest beyond March 31, 2020

 

11,249

 

$

215.56

 

2.1

 

 

 —

 

Options exercisable at March 31, 2020

 

11,249

 

$

215.56

 

2.1

 

 

 —

 

 

Schedule of weighted-average assumptions used to calculate the estimated fair value of each stock option

 

 

 

 

 

    

Fiscal Year Ended

 

 

    

March 31, 2019

 

Risk-free interest rate

 

2.5%

 

Contractual term

 

5 years

 

Expected volatility

 

76%

 

 

Restricted stock units  
Summary of restricted stock activity

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

Average Grant

 

 

 

 

 

Date Fair

 

Restricted Stock Units and Performance Restricted Stock Units

 

Shares

 

Value

 

Nonvested restricted stock units outstanding at March 31, 2019

    

221,778

    

$

10.20

 

Granted

 

262,370

 

 

4.74

 

Vested and issued

 

(100,296)

 

 

9.84

 

Forfeited

 

(53,022)

 

 

8.34

 

Nonvested restricted stock units outstanding at March 31, 2020

 

330,830

 

 

6.28

 

Restricted stock units expected to vest beyond March 31, 2020

 

330,830

 

$

6.28

 

 

Schedule of additional information

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended

 

 

 

 

March 31,

 

 

    

    

2020

    

2019

 

Restricted stock compensation expense (in thousands)

 

    

$

913

    

$

907

 

Aggregate fair value of restricted stock units vested and issued (in thousands)

 

    

$

384

    

$

748

 

Weighted average grant date fair value of restricted stock units granted during the period

 

    

$

4.74

    

$

0.98